Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CELYAD SA/ADRSierra OncologyPhaseBio PharmaceuticalsIDEAYA BiosciencesNewron Pharmaceuticals
SymbolNASDAQ:CYADNASDAQ:SRRANASDAQ:PHASNASDAQ:IDYAOTCMKTS:NWPHF
Price Information
Current Price$8.07$10.27$3.35$4.23$7.50
52 Week RangeBuyBuyBuyBuyN/A
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyN/A
Consensus Price Target$27.33$1.20$20.67$18.00N/A
% Upside from Price Target238.70% upside-88.32% downside516.92% upside325.53% upsideN/A
Trade Information
Market Cap$106.10 million$109.05 million$92.34 million$94.81 million$133.80 million
Beta1.361.151.95N/A0.13
Average Volume15,63933,152342,24860,80610
Sales & Book Value
Annual Revenue$10,000.00N/A$670,000.00N/A$7.88 million
Price / Sales11,249.58N/A143.85N/A16.98
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$6.65 per share$8.93 per share$2.08 per shareN/A$3.63 per share
Price / Book1.21N/A1.61N/A2.07
Profitability
Net Income$-44,200,000.00$-88,280,000.00$-23,850,000.00N/A$-22,640,000.00
EPS($2.57)($19.52)($4.49)($3.36)($1.27)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio∞N/AN/AN/A2.69
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-1,768.29%N/AN/A
Return on Equity (ROE)N/A-76.01%-53.00%N/AN/A
Return on Assets (ROA)N/A-56.31%-43.27%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.07%N/A0.13%0.06%0.22%
Current Ratio3.59%2.32%13.98%14.65%8.29%
Quick RatioN/A2.32%13.98%18.86%N/A
Ownership Information
Institutional Ownership Percentage7.84%N/A67.69%51.16%N/A
Insider Ownership PercentageN/A67.68%17.00%N/AN/A
Miscellaneous
EmployeesN/A79225624
Shares Outstanding13.94 million10.40 million28.77 million20.34 million17.84 million
Next Earnings DateN/A5/13/2020 (Estimated)3/31/2020 (Estimated)6/23/2020 (Estimated)6/4/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel